ADMA

ADMA BIOLOGICS, INC.

8.87^post−$0.04 (−0.45%)at close +$0.00 (+0.00%)

tap the star to start your desk

as of 23:18:44 UTCnext report Aug 10 · 5d

Earnings Room‹ back to ADMA

The report

fiscal Q2 2026 · from the company's notice

Aug 10after close5days out

Expected movement

market-implied · at the Aug 4 close

±11.7%is what the chain prices for this report itself, with the ordinary drift of the days around it taken out. Not a view we hold.

The full straddle prices ±16.1% over the 17 days to expiry; the rest of that is everyday movement, which the chain prices at 75% annualized.

expiry Aug 21 · first after the reportATM strike 9straddle 1.67ATM IV 109% vs 89% at Sep 18× 0.85 straddle-to-rangespot 8.87

Blast radius

3 linked · N-PORT + EDGAR

If ADMA moves ±16.1% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.

XBIfundState Street SPDR S&P Biotech ETF0.60% of the fund0.10%IWMfundiShares Russell 2000 ETF0.07% of the fund0.01%VTIfundVanguard Total Stock Market Index Fund0.00% of the fund0.00%

Positioning

Butterfly Ladder

No options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.

The record

expected in pale · actual in full color

2/8reports moved further than the options market had pricedtypically ±8.3% realized vs ±12.4% priced

May 6 '26±14.1%→−16.0%×1.14

Feb 25 '26±10.9%→−3.2%×0.29

Jan 12 '26±6.8%→−0.1%×0.02

Nov 5 '25±16.3%→−8.7%×0.54

Aug 6 '25±13.1%→−9.7%×0.74

May 7 '25±12.2%→−10.2%×0.83

Mar 3 '25±15.0%→+7.5%×0.50

Jan 13 '25±10.6%→−11.2%×1.05

pale = implied the day beforeink = the next day's close× = realized ÷ implied

2-quarter memory

Q1 FY26 · reported 0.19 · rev $114M

record note

The note composes when the report lands. Nothing is written for a quarter that hasn't been read.